Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2009 - 2026)

Zimmer Biomet Holdings (ZBH) recorded quarterly Shares Outstanding (Weighted Average) of $195.0 million in Q1 2026, down 1.52% quarter-over-quarter from $198.0 million in Q4 2025, and down 1.96% on a YoY basis from $198.9 million in Q1 2025.

Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $195.0 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 1.96% year-over-year to $195.0 million; the TTM figure through Mar 2026 stood at $195.0 million (down 1.96% YoY), while the FY2025 annual figure was $198.0 million, down 2.51% from the prior year.
  • Shares Outstanding (Weighted Average) was $195.0 million for Q1 2026 at Zimmer Biomet Holdings, down from $198.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $209.8 million in Q3 2022 to a low of $195.0 million in Q1 2026.
  • Historically, Shares Outstanding (Weighted Average) has averaged $204.0 million across 5 years, with a median of $205.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) retreated 0.38% in 2023, then declined 3.41% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $209.6 million in 2022, then declined by 0.43% to $208.7 million in 2023, then fell by 2.68% to $203.1 million in 2024, then declined by 2.51% to $198.0 million in 2025, then declined by 1.52% to $195.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $195.0 million (Q1 2026), $198.0 million (Q4 2025), and $198.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 Zimmer Biomet Holdings 17.27 Bn 16.86 Bn 1.51 Bn 195.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 195.00 Mn
Dec 31, 2025 198.00 Mn
Sep 30, 2025 198.30 Mn
Jun 30, 2025 198.40 Mn
Mar 31, 2025 198.90 Mn
Dec 31, 2024 203.10 Mn
Sep 30, 2024 202.30 Mn
Jun 30, 2024 205.40 Mn
Mar 31, 2024 205.20 Mn
Dec 31, 2023 208.70 Mn
Sep 30, 2023 209.00 Mn
Jun 30, 2023 208.60 Mn
Mar 31, 2023 209.40 Mn
Dec 31, 2022 209.60 Mn
Sep 30, 2022 209.80 Mn
Sep 30, 2014 169.00 Mn
Jun 30, 2014 168.40 Mn
Mar 31, 2014 169.10 Mn
Dec 31, 2013 169.60 Mn
Sep 30, 2013 170.00 Mn